Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome
{{output}}
Radioiodine ((131)I) therapy of benign thyroid diseases was introduced 70 yr ago, and the patients treated since then are probably numbered in the millions. Fifty to 90% of hyperthyroid patients are cured within 1 yr after (131)I therapy. With longer follow-up... ...
